dapagliflozin 5 MG / saxagliptin 5 MG Oral Tablet
RxNorm concept 2169274, clinical drug (scd). Prescribable name: dapagliflozin 5 MG / sAXagliptin 5 MG Oral Tablet.
- RxCUI
- 2169274
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2169274 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
dapagliflozin 5 MG (as dapagliflozin propanediol 6.15 MG) / sAXagliptin 5 MG (as sAXagliptin HCl) Oral Tablet; dapagliflozin 5 MG (as dapagliflozin propanediol 6.15 MG) / saxagliptin 5 MG (as saxagliptin HCl) Oral Tablet; dapagliflozin 5 MG / sAXagliptin 5 MG Oral Tablet
Related concepts
- saxagliptin 5 MG (SCDC, consists of)
- dapagliflozin 5 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- dapagliflozin 5 MG / saxagliptin 5 MG Oral Tablet [Qtern] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2169274 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2169274 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2169274. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.